Vasowatch Inc

Vasowatch’s mission is to develop and deploy clinical decision support technology to improve the birthing experience for better maternal outcomes. Our product is novel Labor and Delivery technology (US patent pending) that provides continuous monitoring of a mother’s risk for postpartum hemorrhage, excessive blood loss after childbirth, the leading cause of maternal deaths and complications globally. We provide up to ten times greater predictive accuracy hours ahead of delivery, saving lives, reducing maternal complications and cutting obstetrics costs for health systems and payers. We plan to offer our Software as a Medical Device (SaMD) in a broad set of care settings including birthing centers, rural health and home births. With FDA approval, we will pursue World Health Organization pre-qualification, enabling international expansion to another 140M births.